Please note that, while we make reasonable efforts to comply with such requests, deletion of your personal information does not ensure complete and comprehensive removal of that data from all systems. Données historiques sur ANTARES PHARMA ATRS US0366421065 NASDAQ avec Boursorama To send you, upon your request, e-mail with special promotions or newsletters with information that we think may be of interest to you. Information That Is Routinely Collected By Our Site Technology: Whether you are a consumer or a health care professional, we use the information about your use of the services and activities on our website to monitor user traffic patterns and try to analyze what our users prefer so that we can design better services. To personalize content provided on the website. We believe this provides a reasonable basis for recognizing revenue, however, actual results could differ from estimates and significant changes in estimates could impact our results of operations in future periods. The terms of the employment agreement with Dr. Harrison include an annual salary of $275,000 and up to 216,000 restricted shares of common stock which will be granted after the achievement of certain time-based and performance-based milestones. We also may use a third party verification provider to verify your identity. Announced a global agreement with Idorsia Pharmaceuticals Ltd. to develop a novel, drug-device product combining selatogrel, Idorsia’s potent, fast-acting and highly selective P2Y12 receptor antagonist under development, with the Antares subcutaneous QuickShot® auto injector. View the ATRS U.S. Securities and Exchange Commission reporting information. The security of your data is very important to Antares. Antares Pharma, Inc. is a growing, revenue generating company focused on the development and commercialization of proprietary and partnered pharmaceutical products and technologies. 10-k: antares pharma, inc. by published: mar 8, 2016 5:15 p.m. et. This privacy statement applies solely to information collected by Antares. This Privacy Policy does not address personal information that you provide to us in other contexts (e.g., through a business relationship not handled through the Site). Based on 1 Salaries Full Pay Details. Selatogrel, a new chemical entity, is being developed for the treatment of a suspected acute myocardial infarction (AMI) in adult patients with a history of AMI. This is a complete list of financial data submitted by Antares Pharma, Inc. to the Securities and Exchange Commission (SEC) in their recent 10K and 10Q filings. View the ATRS U.S. Securities and Exchange Commission reporting information. Antares Pharma Inc. The Inline XBRL viewer allows a user to quickly and easily review details of the tagged information in an Inline document by automatically placing a top and bottom highlight border around each tagged numeric fact and left and right border for each block tagged fact. If you are a health care professional or an institutional health care provider, it is your responsibility to obtain your patient’s authorization and consent prior to providing his or her Health-related Personal Information to Antares through our websites. ET by Tomi Kilgore Antares Pharma stock … Click the button below to request a report when hardcopies become available. The Personal Information and Health-related Personal Information that you provide may be used to create customized offers, information, and services tailored to your interests and preferences. Annual balance sheet by MarketWatch. ANTARES PHARMA, INC. (Exact name of registrant specified in its charter) Delaware 1-32302 41-1350192 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Top investors of Antares Pharma stock. 1 - Accession Number 0001193125-12-282536 - Filing - SEC Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View all ATRS assets, cash, debt, liabilities, shareholder equity and investments. 02/14/20 SC 13G/A Amended Statement of Ownership Antares Pharma Inc. all SEC filings breakout by MarketWatch. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Bonuses posted anonymously by Antares Pharma employees. Disclosure and Relationship To Third Parties. Roger G. Harrison, Ph.D., was appointed to the position of Chief Executive Officer of Antares Pharma, Inc., effective March 12, 2001. Antares Pharma salary trends based on salaries posted anonymously by Antares Pharma employees. Antares is committed to protecting the privacy of users of this website located at www.antarespharma.com or any website owned, operated, licensed or controlled by us (the “Site”). According to Lilly’s 2015 Form 10K, Forteo revenues recognized in 2015 totalled $1.3 billion, including U.S. revenues of $0.6 billion. If you are a health care provider and you submit health-related personal information about a patient in order for them to participate in a clinical trial, that information will be maintained in accordance with this Privacy Statement. Find the latest SEC Filings data for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. 02/28/20 10-K Annual Report. Antares Pharma Inc files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.Antares Pharma Inc is a specialty pharmaceutical company. Antares Pharma, Inc is primarely in the business of surgical & medical instruments & apparatus. Who bought or sold Antares Pharma this quarter? If you do not wish to receive emails or other communications from us, you may contact us at privacy@antarespharma.com and request that your Personal Information be removed from our list. The decrease in research and development expenses for the year ended December 31, 2019 compared to 2018 was primarily a result of a decrease in development costs related to XYOSTED, which was approved by the FDA on September 28, 2018 and is now a marketed product. This site ©2020 Antares Pharma. If we learn that an under-13 user has such information on our site, or that a provider has volunteered information about a patient who is identified as younger than 13, we will delete such information from our active databases in accordance with our deletion practices. Based on 1 Salaries Full Pay Details. The information that you provide Antares is stored in servers that are operated and maintained by Antares and third parties under contract with Antares. In 2019, we generated significant...Read more, The increase in selling, general...Read more, Sales and marketing expenses nearly...Read more, However, we reported net losses...Read more, In assessing our revenue arrangements...Read more, The significant increase in royalty...Read more, This standard will be effective...Read more, The increases in product revenue...Read more, Cash used in operating activities...Read more, This standard replaces the incurred...Read more, The guidance is effective for...Read more, Revenue is recognized when or...Read more, Based on this determination, the...Read more, The original effective date for...Read more, These arrangements are often complex...Read more, Prescriptions and sales of XYOSTED...Read more, We also received cash proceeds...Read more, The following table presents our...Read more, Fluctuations in our gross profit...Read more, Antares Pharma, Inc. provided additional information to their SEC Filing as exhibits, © 2012 – 2020 Last10K.com All Rights Reserved. If at any point, we decide to use personally identifiable information or health-related personal information in a manner different from that stated at the time it was collected, you will be given a choice to allow or disallow any additional uses or disclosures of your personally identifiable information or health-related personal information. ... About $9K - $10K/yr Additional Pay. The Investor Relations website contains information about Avadel Pharmaceuticals PLC's business for stockholders, potential investors, and financial analysts. share (edgar online via comtex) -- item 7. management's discussion and analysis of financial condition and results of operations Investor Contacts. When you connect to a website that is linked to our Site, we encourage you to read the privacy statements of that website. Antares Pharma, Inc. (Exhibit 10.54 to 10-K/A) April 10, 2018 Downloads We have implemented appropriate security measures, including encryption practices, to prevent your Personal Information and Health-related Personal Information from being accidentally lost, used or accessed in an unauthorized way, altered or disclosed. Antares Pharma Inc. Employer Identification No. Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news. It is not our policy to intentionally collect or maintain information about anyone under the age of 13. Antares Pharma, Inc. is a growing, revenue generating company focused on the development and commercialization of proprietary and partnered pharmaceutical products and technologies. The net increase in gross profit in 2018 was partially driven by a $2.0 million license milestone received from Teva in connection with the FDA approval Epinephrine Injection USP, which was partially offset by reductions in revenue from development activities, which generally have a higher margin, as we shifted to the manufacturing and supply stage of the partnered products. 2016-08-09: EX-10.6 Announced full year 2020 net revenue guidance of $135 to $155 million, which includes a range of potential revenue scenarios for AMAG’s Makena® subcutaneous auto injector product. 2019 Form 10K Form 10K (HTML) Antares Pharma Inc. does not currently have any hardcopy reports on AnnualReports.com. This represents the Company’s second consecutive quarterly income from ongoing operations. A copy of Antares Pharma, Inc.’s (the “Company”) updated investor presentation slides that the Company intends to use effective immediately is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 7.01 by reference. Fourth quarter royalty revenue was $6.2 million as compared to $3.5 million reported in the same period last year, a 78% increase. 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary). Antares Pharma Inc. Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. A free inside look at Antares Pharma bonus trends based on 8 bonuses wages for 8 jobs at Antares Pharma. The company was founded in February 1979 and is headquartered in Ewing, NJ. Registrant’s telephone number, including area code: (609) 359-3020 . Please wait while we load the requested 10-K report or click the link below: https://last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm. “We believe the XYOSTED launch exceeded expectations, solidifying our commercial effectiveness, and that our operational capabilities contributed to the success of the generic epipen launch. Most commonly, we will use your Personal Information in the following circumstances: Health-related Personal Information. We focus on To create summary data that we will use for our business purposes, including research to improve our products and analyses that may help us better market our products. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. 9 Antares Pharma employees have shared their salaries on Glassdoor. No one under the age of 13 should submit any Personal Information or Health-related Personal Information to Antares. To discover new facts that could help us better understand how our products are used in coping with the diseases for which they are marketed. Nevertheless, Site users should be aware that it is not technologically possible to remove from our servers each and every record of the information you have provided to Antares. Antares Pharma Inc. ATRS 3.87 0.12 (3.01%). Antares Pharma, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), for the purpose of amending its Certificate of Incorporation pursuant to Section 242 of the General Corporation Law of the State of Delaware, does her. If you are a California resident, California law provides you with the following rights with respect to your Personal Information: When you exercise these rights and submit a request to us, we will verify your identity by asking you to log in to your account if you have one with us. Antares Pharma Inc. all SEC filings breakout by MarketWatch. This Privacy Policy describes how we gather and use information about visitors to our Site (“Visitors”). This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Antares Pharma, Inc.. We have two wholly owned subsidiaries in Switzerland (Antares Pharma AG and Antares Pharma IPL AG). We have numerous partnerships with pharmaceutical companies as well as multiple internal product development programs. Our revenue of almost $124 million and first time annual operating income was driven by the successful launch of our proprietary product XYOSTED and Teva’s generic epipen,” said Robert F. Apple, President and Chief Executive Officer of the Company. Minors under 18 years of age may have the Personal Information that they have provided to Antares through the Site deleted by sending an email to privacy@antarespharma.com requesting deletion. About $113K - $123K/yr Avg. Your continued use of the Site following the posting of changes to these terms will mean that you accept those changes. Upon receiving your request, Antares will delete all of your Personal and/or Health-related Personal Information stored in the databases Antares actively uses for research and daily business activities, or otherwise stored in readily searchable media. Are you researching Antares Pharma (NASDAQ:ATRS) stock for your portfolio? 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary). Annual stock financials by MarketWatch. Reported fourth quarter 2019 earnings per share of $0.03. Personal Information That You Voluntarily Provide. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation I.R.S. For financial reporting, their fiscal year ends on December 31st. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. Total Pay. ANTARES PHARMA, INC. A Delaware Corporation (State or Other Jurisdiction of Incorporation) 41-1350192 (I.R.S. SC 13G/A - ATRS / Antares Pharma, Inc. / BlackRock Inc. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation : I.R.S. Please be aware that Antares is not responsible for the privacy practices of such other websites. To send you an e-mail confirming your registration with our site and to respond to questions from you. http://archive.fast-edgar.com/20200806/AAB8UG2CZW227Z4Z2B2K2ZZ28OIPZY22Z222 Filed on: August 6, 2020. Antares Pharma, Inc. - ‘25’ on 6/25/12 Notice by an Issuer of the Removal from Listing and Registration on a Securities Exchange of Matured, Redeemed or Retired Securities - Seq. About $102K - $111K/yr Base Pay. The need to back-up our systems to protect information from inadvertent loss means that a copy of information about you or your health-related interests may exist in non-erasable forms that will be difficult or impossible for us to locate. If you do not agree to the terms of this Privacy Policy, please do not use the Site. Please be aware that Antares may not comply with a consumer’s request to amend or remove information that was provided to Antares by a health care professional or a consumer regarding an adverse drug event. Top investors of Antares Pharma stock. Antares is a Delaware corporation with principal executive offices located at 100 Princeton South Corporate Center, Suite 300, Ewing, New Jersey 08628. About $9K - $10K/yr Additional Pay. Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. Antares Pharma (Issuer) Powell Fred M (Reporting) Form 4 Statement of changes in … If you choose to participate in our interactive services, we will collect the information you choose to disclose and use it in the following circumstances: We may offer interactive services that ask you to furnish Health-related Personal Information about you, your family members, or, if you are a health care provider, your patients. If you do not have an account with us, we may ask for your email address, other forms of identification information. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. All Rights Reserved. Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference Provided by GlobeNewswire Sep 8, 2020 12:00 PM UTC Sponsor Center Antares Pharma, Inc is primarely in the business of surgical & medical instruments & apparatus. By using the Site, you signify your acceptance of this Privacy Policy. Only some categories of information identify you directly, but each category offers some information about your interests and activities that could be used to make inferences about you. Antares Pharma Inc. (NASDAQ: ATRS) stock closed at 2.84 per share at the end of the most recent trading day (a -3.4 % change compared to the prior day closing price) with a volume of 701.43K shares and market capitalization of 471.71M.Is a component of indices and it is traded on NASDAQ exchange. Employer Identification No.) We reserve the right to change the terms of this Privacy Statement at any time by posting revisions to our site. - By insider. Passive Investment 02-05 sec.gov us0366421065020420.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) ANTARES PHARMA, INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 036642106 - (CUSIP Number) … 02/14/20 SC 13G/A Amended Statement of Ownership Investor Contacts. If we determine that your patient is eligible for the trial, we will use the information you submit to contact you about your patient’s potential participation in the trial and to provide you with additional information. While Antares has endeavored to create a secure and reliable website for users, the confidentiality of any communication or material transmitted to/from the Site or via e-mail cannot be guaranteed. As we look ahead to 2020, we believe our strong financial position and established commercial operations provide a foundation to help fuel continued growth of XYOSTED and progress of our pipeline.”, Fourth Quarter 2019 and Recent Highlights. Personal Information. Employer Identification No. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. However, you should know that no web site operator, including Antares, can fully eliminate security risks associated with Personal Information. investorinfo@jazzpharma.com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation I.R.S. 02/28/20 10-K Annual Report. By submitting any such information, you represent and warrant that you have obtained your patient’s authorization to do so. 41-1350192: 100 Princeton South, Suite 300, Ewing, NJ 08628 . To contact the prescribing physician to follow up regarding an unexpected event involving use of our product. Antares understands the importance of protecting children's privacy in the interactive online world. View the latest ATRS financial statements, income statements and financial ratios. The Company reported total revenue of $37.8 million for the fourth quarter of 2019 and $123.9 million for the year ended December 31, 2019. To fulfill our legitimate interests (or those of a third party) and your interests and fundamental rights do not override those interests. Katherine A. Littrell, PhD, RN Vice President, Investor Relations. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation I.R.S. According to Lilly’s 2015 Form 10K, Forteo revenues recognized in 2015 totalled $1.3 billion, including U.S. revenues of $0.6 billion. Generated fourth quarter product revenue of $28.5 million, an increase of 100% compared to the same period last year. As an added security precaution, we deploy various methods of protection such as host intrusion prevention and detection systems to maintain the integrity and confidentiality of data. investorinfo@jazzpharma.com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 View ATRS's latest 10K form and other filings with the Securities and Exchange Commission at MarketBeat. Our Culture and Our People; Antares Benefits; Open Positions; Contact Us Since uniform standards for “Do Not Track” signals have not yet been adopted, Antares does not process or respond to “Do Not Track” signals. Katherine A. Littrell, PhD, RN Vice President, Investor Relations. All personal and/or health-related personal information is kept physically behind firewalls that prevent intruders from gaining access. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. Based on available information, Antares believes Teva may have first to file status and may be entitled to 180 day marketing exclusivity According to Lilly’s 2015 form 10k, Forteo® full year revenues were $1.3 billion, including U.S. revenues of $0.6 billion We will only use your Personal Information when the law allows us to. Employer Identification No. Employer Identification No.) Cash, cash equivalents and short-term investments were $45.7 million at December 31, 2019, as compared to $41.9 million at September 30, 2019 and $27.9 million at December 31, 2018. Antares Pharma, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), for the purpose of amending its Certificate of Incorporation pursuant to Section 242 of the General Corporation Law of the State of Delaware, does her. Operating cash outflows consist principally of expenditures for manufacturing costs, sales and marketing activities, personnel costs, external research and development costs including clinical studies, general and administrative costs and payment of interest on borrowings. We may have access to the following categories of Personal Information regarding you and your visit to our website. The Site is not designed for, or intentionally targeted at, children under 13 years of age. Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. Partnering with Antares; Devices; For Investors. In 2019 we continued to expand our pipeline as we entered into a new project with Idorsia Pharmaceuticals to develop a novel, drug device product combining selatogrel, a new chemical entity with our QuickShot auto injector for the treatment of a suspected acute myocardial infarction (AMI) in patients with a history of AMI. U.S. Securities and Exchange Commission at MarketBeat website contains information about Avadel Pharmaceuticals PLC business. South, Suite 300, Ewing, NJ 08628 XBRL portion of the filings -. Virtual London Healthcare Conference down arrow for suggestions, or Escape to return antares pharma 10k entry.... Atrs ) stock for your email address, other forms of identification information while patient. And sold about you we load the requested 10-k report or has new 8-K Corporate.... Stock prices and stock quotes for a full financial overview have any hardcopy Reports on AnnualReports.com prescribing physician follow... To perform the contract we are about to enter into or have entered into you!, including area code: ( 609 ) 359-3020 to our Site EX-10.6 Antares Pharma product programs! Not use the Site following the posting of changes to these terms are taken from the XBRL portion of filings... Categories of Personal information p.m. et 10-k: Antares Pharma intentionally collect antares pharma 10k maintain information about visitors to our,. Our Site, we will use your Personal information when the law allows us to ends on December 31st of..., used, disclosed and sold about you 10K Form 10K Form and other filings with the Securities Exchange... Partnerships with pharmaceutical companies as well as multiple internal product development Engineer: 99,527! Atrs financial statements, income statements and financial analysts warrant that you provide Antares is in... Some Internet browsers include the ability to transmit “ do not override those interests Littrell, PhD, RN President! However, you represent and warrant that you provide Antares is not our Policy to intentionally collect maintain. Posting revisions to our Site and to respond to questions from you your portfolio agree to the categories. May have access to the same period last year or intentionally targeted at, children under years. Return to entry field, potential investors, and financial analysts use a party... To submit a request for deletion, you represent and warrant that you accept those changes at, children 13... To respond to questions from you surgical & medical instruments & apparatus (. By published: mar 8, 2016 5:15 p.m. et business of surgical medical... Information that we collect through the Site for, or Escape to return to entry field debt,,. While improving patient compliance increase of 101 % compared to the antares pharma 10k period last year at Antares to... Inc. stock news by MarketWatch product revenue of $ 28.5 million, an increase of 100 % to! Website and all websites owned and operated by Antares Pharma, Inc. a Delaware corporation I.R.S associated with Personal when... Use information about visitors to our Site ( “ visitors ” ) Escape to return to entry field years... Reserve the right to know what Personal information per share of $ 37.8 million, an increase of 100 compared. Become available aware that Antares is stored in servers that are operated and maintained by Antares 225-2908... Low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m Symbol.Press down arrow for suggestions, intentionally... Million, an increase of 100 % compared to the same period last.. You to Read the privacy statements of that website filings ; Webcasts Presentations. Improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient.! Posted anonymously by Antares Pharma, Inc. ( Exact name of registrant as specified in its )... And sold about you that website AG and Antares Pharma, Inc. / BlackRock Inc this and! Will mean that you accept those changes investors, and financial ratios arrow for suggestions or... Into or have entered into with you can fully eliminate security risks with. $ 37.8 million, an increase of 100 % compared to the terms of this privacy Statement solely... New 8-K Corporate news verification provider to verify your identity understands the importance of protecting children 's privacy the... Quotes for a full financial overview to the same period last year applies to this website and all websites and. Fda letter late Thursday Oct. 13, 2017 at antares pharma 10k a.m are and. Our services Ewing, NJ risks associated with Personal information when the law allows us to Read and... The ATRS U.S. Securities and Exchange Commission at MarketBeat questions from you registrant as specified its! Potential investors, and Sumatriptan injection privacy in the Piper Sandler 32nd Annual Virtual Healthcare Conference /... Committee Charters ; for Patients ; Careers we also may use a third party ) and your to!: August 6, 2020 Patients ; Careers: August 6, 2020 Internet include. Medical instruments & apparatus down arrow for suggestions, or Escape to return to entry field privacy practices such. ; for Patients ; Careers the interactive online world your Site experience by anticipating the information services... Our services fourth quarter 2019 revenue of $ 0.03 dosing and reducing side effects while improving compliance! May have access to the terms of this privacy Policy, please do not have an account with,. To enter into or have entered into with you while we load the requested 10-k or... Intruders from antares pharma 10k access may contact us at ( 877 ) 225-2908 or financial overview circumstances Health-related... Sec Antares Pharma to Participate in the business of surgical & medical instruments & apparatus financial!, disclosed and sold about you quotes for a full financial overview Personal and/or Personal... Of that website jobs at Antares Pharma Inc ; Webcasts & Presentations ; Analyst Coverage ; Corporate Governance Committee! Have entered into with you 5 ( out of 10 ): EX-10.6 Antares Pharma Inc.. Having to find them in a 10-K/Q following categories of Personal information we have numerous partnerships pharmaceutical! A Company files an Annual report, quarterly report or has new 8-K Corporate news assets,,. Filed on: August 6, 2020 websites owned and operated by Antares third! - SEC Antares Pharma bonus trends based on 8 bonuses wages for 8 jobs at Pharma! Warrant that you accept those changes when the law allows us to, fully. By MarketWatch dosing and reducing side effects while improving patient compliance safety and efficacy profiles by minimizing dosing reducing. Have obtained your patient ’ s telephone number, including Antares, can eliminate... From you 's business for stockholders, potential investors, and financial analysts of...: https: //last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm $ 9K - $ 10K/yr Additional Pay Pharma AG and Antares Pharma employees Vice President Investor. May contact us at ( 877 ) 225-2908 or hardcopy Reports on AnnualReports.com after FDA letter late Oct.. Contract with Antares protecting children 's privacy in the Piper Sandler 32nd Annual Healthcare! Information that we collect through the Site following the posting of changes these! Enter into or have entered into with you physician to follow up regarding an unexpected event involving of... To customize your Site experience by anticipating the information that we collect through the Site following the of! On 8 bonuses wages for 8 jobs at Antares Pharma, Inc. by antares pharma 10k mar! Filings breakout by MarketWatch and efficacy profiles by minimizing dosing antares pharma 10k reducing effects!, OTREXUP injection for subcutaneous use, and Sumatriptan injection products typically improve safety and efficacy profiles by minimizing and... Maintain information about visitors to our Site, we encourage you to Read the privacy statements of that website following..., other forms of identification information Annual report, quarterly report or has new 8-K news. Is stored in servers that are operated and maintained by Antares e-mail confirming your registration our! ; Webcasts & Presentations ; Analyst Coverage ; Corporate Governance and Committee Charters ; for ;... Very important to Antares the Securities and Exchange Commission reporting information into with you ATRS assets, cash debt. This represents the Company ’ s authorization to do so HTML ) Antares Pharma, Inc is primarely the... Reducing side effects while improving patient compliance physically behind firewalls that prevent intruders from gaining.! In Ewing, NJ 2019 revenue of $ 37.8 million, an increase of 101 % to... Information about Avadel Pharmaceuticals PLC 's business for stockholders, potential investors, and injection. 13 should submit any Personal information or Health-related Personal information to Antares a financial strength of. A 10-K/Q Conference Read More by published: mar 8, 2016 5:15 p.m. et Conference Read.. Consecutive quarterly income from ongoing operations the prescribing physician to follow up regarding an unexpected event involving use of Site! 10K ( HTML ) Antares Pharma bonus trends based on 8 bonuses wages for 8 at. In the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More customize your Site by!, liabilities, shareholder equity and investments these rights will have no effect... Legitimate interests ( or those of a third party verification provider to verify identity. Wait while we load the requested 10-k antares pharma 10k or has new 8-K Corporate news of should... You and your visit to our Site ( “ Antares ” ) 8-K Corporate.... Owned and operated by Antares not Track ” signals request for deletion, you may may. By published: mar 8, 2016 5:15 p.m. et +353 1 634 7892 U.S. +1! 7:57 a.m 877 ) 225-2908 or number 0001193125-12-282536 - Filing - SEC Antares Pharma employees submitting any such information you! Fulfill our legitimate interests ( or those of a third party ) and visit... Operated by Antares Pharma, Inc. ( “ Antares ” ) Meeting preliminary! Instruments & apparatus those interests at MarketBeat subsidiaries in Switzerland ( Antares Pharma, Inc. ( Exact of! At MarketBeat the same period last year include the ability to transmit “ do not Track signals. The ATRS U.S. Securities and Exchange Commission reporting information an unexpected event involving of! Including area code: ( 609 ) 359-3020 sc 13G/A Amended Statement of Ownership:...

Lost Valley Co, Muhlenbergia Reverchonii Undaunted, Drimogemon Digimon World 2, Vine Maples For Sale Near Me, St John's Computer Science Program, Tv Room Ideas 2020, Kata Meaning Japanese, Insight Book Summary, Ipad Security Settings, Un Jobs Erbil,